A recent Bernstein note named eight European pharmaceutical stocks as “outperform,” arguing the sector's fundamentals are mispriced at parity to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE